Protherics PLC
Notification of Major Interests in Shares
London, UK; Brentwood, TN, US: 26 February 2008 - Protherics PLC ("Protherics"
or the "Company"), the international biopharmaceutical company focused on
critical care and cancer, announces that, on 25 February 2008, in accordance
with the Transparency Obligations Directive, a notification of interest in the
ordinary share capital of the Company was received from AXA Investment Managers
UK Limited on behalf of AXA S.A. and its Group Companies ("AXA"). Details of
the notification are as follows:
1. Reason for the notification (please tick the appropriate box or boxes)
An acquisition of voting rights X
An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached
An event changing the breakdown of voting rights
Other (please specify):
2. Full name of person(s) subject to the AXA S.A., 25 Avenue Matignon, 75008 Paris and its
notification obligation: group of companies.
3. Full name of shareholder(s) (if different
from 2.):
4. Date of the transaction (and date on which 24 February 2008
the threshold is crossed or reached if
different):
5. Date on which issuer notified: 25 February 2008
6. Threshold(s) that is/are crossed or reached: 13%
7. Notified details:
A: Voting rights attached to shares
Class/type of Situation previous to Resulting situation after the triggering transaction
shares the Triggering
transaction
if possible using Number of Number of Number of Number of voting rights % of voting rights
the ISIN CODE Shares Voting shares
Rights Direct Direct Indirect Direct Indirect
0702920 44,103,463 44,103,463 741,666 741,666 43,692,111 0.22% 12.85%
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration date Exercise/ Conversion Number of voting rights % of voting rights
instrument Period/ Date that may be acquired if
the instrument is
exercised/ converted.
Total (A+B)
Number of voting rights % of voting rights
44,433,777 13.07%
8. Chain of controlled undertakings through which the voting rights and/or the financial instruments are
effectively held, if applicable :
Name of Company/Fund Number of Shares % of issued share capital
AXA UK Investment Co ICVC 574,090 0.16887
UK Smaller Companies Fund
Indirect
Sun Life Pensions Management Ltd 25,000 0.00735
Direct
Sun Life Unit Assurance Ltd 53,913 0.01586
FTSE All Share Tracker Life
Direct
Sun Life Pensions Management 294,874 0.08674
FTSE All Share Tracker
Direct
AXA Framlington 850,000 0.25003
SEI UK Equity
Indirect
AXA Framlington 1,851,468 0.54462
St James Place Exempt (Pens) Fund
Indirect
AXA Framlington 1,909,918 0.56181
St James Place Net (Life) Fund
Indirect
AXA Framlington 459,865 0.13527
St James Place Offshore Fund
Indirect
AXA Framlington 639,353 0.18807
Daimler Chrysler
Indirect
AXA Framlington 3,120,333 0.91787
Throgmorton Trust
Indirect
AXA Framlington 15,013,453 4.41630
UK Select Ops
Indirect
AXA Framlington 13,753,131 4.04557
Equity Income
Indirect
AXA Framlington 2,000,000 0.58831
Managed Balanced
Indirect
AXA Framlington 1,500,000 0.44123
UK Smaller Companies
Indirect
AXA Framlington 500,000 0.14708
BAE Systems Pensions Fund CIF Trustees
Indirect
AXA Framlington 220,000 0.06471
BAE Systems 2000 Pensions Fund
Indirect
Framlington onshore private clients 975,500 0.28695
Indirect
Axa Sun Life With Profits Passive 226,817 0.06672
Direct
Axa Sun Life With Profits Passive 141,062 0.04149
Direct
AXA Framlington 325,000 0.09560
St James Place Internal Equity & Income UT
Indirect
Total Direct 741,666 0.21817
Total Indirect 43,692,111 12.85230
TOTAL 44,433,777 13.07047
Proxy Voting:
9. Name of the proxy holder:
10. Number of voting rights proxy holder will cease to hold:
11. Date on which proxy holder will cease to hold voting
rights:
12. Additional information:
| Ends |
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, Lara Mott +44 (0) 20 7831 3113
New York: John Capodanno, Jonathan Birt +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange
Protherics PLC announces Holding(s) in Company
| Source: Protherics PLC
Cheshire, UK--(Marketwire - February 26, 2008) -